|
[1]肝性脑病诊断治疗专家委员会.肝性脑病诊断治疗专家共识[J].中华实验和临床感染病杂志, 2009, 3 (4) :449-473.
|
|
[2]Rikkers L, Jenko P, Rudman D, et al.Subclinical hepatic encephalopathy:detection, prevalence and relationship to nitrogen metabolism[J].Gastroenterology, 1978, 75 (3) :462-469.
|
|
[3]Ferenci P, Lockwork A, Mullen, et al.Hepatic encephalopathy:definition, nomenclature, diagnosis and quanitification:final report of the working party at the 11th World Congress of Gastroenterology.Vienna 1998[J].Hepatology, 2002, 35 (3) :716-721.
|
|
[4]李瑜元, 聂玉强, 沙卫红, 等.亚临床型肝性脑病的发病率调查[J].中华内科杂志, 2000, 39 (9) :625-626.
|
|
[5]McPhail MJ, Bajaj JS, Thomas HC, et al.Pathogenesis and diagnosis of hepatic encephalopathy[J].Expert Rev Gastroenterol Hepatol.2010, 4 (3) :365-378.
|
|
[6]Bass NM.Review article:the current pharmacological therapies for hepatic encephalopathy[J].Aliment Pharmacol Ther, 2007, 25 (Suppl 1) :23-31.
|
|
[7]De Soarez PC, Oliveira AC, Padovan J, et al.A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment[J].Arq Gastroenterol, 2009, 46 (3) :241-247.
|
|
[8]Jiang Q, Jiang XH, Zheng MH, et al.L-Ornithine-l-aspartate in the management of hepatic encephalopathy:a meta-analysis[J].J Gastroenterol Hepatol, 2009, 24 (1) :9-14.
|
|
[9]曾峥, 李瑜元.乳果糖干预治疗对亚临床肝性脑病病程的影响[J].中华医学杂志, 2003, 83 (13) :1126-1129.
|
|
[10]刘冠军, 王合群, 王良超.门冬氨酸鸟氨酸治疗肝性脑病55例疗效观察[J].临床医学, 2010, 30 (6) :60-61.
|
|
[11]周莹群, 陈世耀, 郭传勇等.左旋门冬氨酸鸟氨酸治疗亚临床肝性脑病的生命质量研究[J].胃肠病学和肝病学杂志, 2009, 18 (1) :48-51.
|
DownLoad: